AI in Biotechnology: Global Markets

The global market for AI in biotechnology was valued at $3.8 billion in 2024. The market is estimated to grow from $4.6 billion in 2025 to $11.4 billion by 2030, at a compound annual growth rate (CAGR) of 20% from 2025 to 2030.

Artificial intelligence (AI) is transforming the biotech industry by enabling faster, more precise and highly scalable operations in genetic engineering, personalized medicine, agricultural biotech and drug discovery. Biotech companies are using machine learning (ML) algorithms to evaluate complex biological data, predict protein structures, discover new drug candidates and improve diagnostic accuracy, including predictive analytics for early disease identification. AI also helps in optimizing manufacturing processes and supply chains, enabling it to have an impact across the entire biotech value chain.

Report Scope

The report analyzes the trends in the global market for AI in biotechnology. It includes global revenue ($ millions) for the base year of 2024 and estimated data for the forecast period 2025 through 2030. The market is segmented by product type (software and services), deployment (cloud-based and on-premises), application and end user. Applications consist of drug discovery, clinical trials, diagnostics and others. End users consist of pharmaceutical and biotech companies, academic research institutes, contract R&D organizations (CROs/CDMOs) and others. The regions covered in this study are North America, Europe, Asia-Pacific, the Middle East and Africa, and South America, with analysis of the markets in the U.S., Canada, Mexico, Germany, the U.K., Italy, France, Spain, the Rest of Europe, China, Japan, India, South Korea and the Rest of Asia-Pacific.

The report focuses on the trends and challenges that affect the market. It includes an analysis of the competitive landscape, with the ranking of leading companies and their market shares. It offers company profiles that covers such details as financials, product portfolio and recent developments. It analyzes companies’ environmental, social and corporate governance (ESG) initiatives.

Report Includes

50 data tables and 57 additional tables
An analysis of the current and future global markets for artificial intelligence (AI) in biotechnology
Analyses of the global market trends, with historic revenue data (sales figures) from 2022 to 2024, estimates for 2025, and projected CAGRs through 2030
Estimates of the size of the market and revenue prospects, along with a corresponding market share analysis based on product type, application, deployment type, end user, and region
Facts and figures pertaining to market dynamics, technological advancements, regulations, prospects and the impact of macroeconomic variables
Discussion of the underlying opportunities and potential, with the development of novel products, drug discovery, clinical trials and other related applications
Insights derived from Porter’s Five Forces model and global supply chain analyses
Overview of sustainability trends and ESG developments, with emphasis on consumer attitudes, as well as the ESG risk ratings and practices of leading companies
Analysis of the industry structure, including companies’ market shares and rankings, strategic alliances, M&A activity and a venture funding outlook
Profiles of the leading companies, including NVIDIA Corp., Tempus AI Inc., Recursion Pharmaceuticals, Schrödinger Inc., and Sophia Genetics

Chapter 1 Executive Summary

Market Outlook
Scope of Report
Market Summary
Overview
Current Market Scenario
Segmental Analysis
Regional Market Insights
Emerging Technologies
Conclusion

Chapter 2 Market Overview

Overview
Potential Applications of AI in Biotechnology
Use Cases
Use Case 1: Drug Discovery
Use Case 2: Personalized Medicine
AI's Impact on the Biotech Value Chain
Macroeconomic Factors Analysis
Demographic Factors
Geopolitical Factors
Impact of U.S. Tariffs
Porter's Five Forces Analysis

Chapter 3 Market Dynamics

Market Dynamics
Market Drivers
Need for More Effective Drug Discovery and Development Process
Shift to Personalized Medicine
Growing Demand for Effective and Early Diagnosis
Rising Investments in AI in Biopharmaceuticals
Aging Population and the Growing Prevalence of Chronic Diseases
Market Restraints
Data Quality and Bias
Integration Hurdles
Ethical Concerns
Market Opportunities
AI in Synthetic Biology
Convergence of AI and Quantum Computing

Chapter 4 Regulatory Landscape

Regulatory Scenario
United States
Europe
Asia-Pacific

Chapter 5 Emerging Technologies and Developments

Emerging Trends/Technologies
Key Takeaways
Agentic AI
Generative AI
Federated Learning
Advanced Neural Networks

Chapter 6 Market Segmentation Analysis

Overview
Segmentation Breakdown
Market Analysis by Product Type
Key Takeaways
Software
Services
Market Analysis by Deployment Type
Key Takeaways
Cloud-based
On-premises
Market Analysis by Application
Key Takeaways
Drug Discovery
Clinical Trials and Optimization
Diagnostics
Other Applications
Market Analysis by End User
Key Takeaways
Pharmaceutical and Biotechnology Companies
Academic and Research Institutes
Contract Manufacturing and Development Organizations
Other End Users
Geographic Breakdown
Market Analysis by Region
Key Takeaways
North America
Europe
Asia-Pacific
Rest of the World

Chapter 7 Competitive Intelligence

Key Takeaways
Competitive Analysis
Strategic Initiatives
Mergers and Acquisitions
Agreements, Collaborations and Partnerships
Investment Landscape

Chapter 8 Sustainability in AI in Biotechnology Market: An ESG Perspective

Introduction to ESG
Sustainability Trends and Company Initiatives
ESG Risk Ratings
Concluding Remarks

Chapter 9 Appendix

Research Methodology
Sources
Abbreviations
Company Profiles
ABCELLERA BIOLOGICS INC.
ABSCI CORP.
ATOMWISE INC.
BENEVOLENTAI
DNANEXUS INC.
EUROFINS SCIENTIFIC
ILLUMINA INC.
INSILICO MEDICINE
NVIDIA CORP.
QIAGEN
RECURSION
SCHRODINGER INC.
SOPHIA GENETICS
TEMPUS AI INC.
XTALPI INC.
Other Emerging Companies in the Market

List of Tables

Summary Table: Global Market for AI in Biotechnology, by Region, Through 2030
Table 1: Applications of AI in Biotechnology
Table 2: Global Incidence and Mortality Cancer Rates, by WHO Region, 2022
Table 3: Global Market for AI in Biotechnology, by Product Type, Through 2030
Table 4: Software Platforms
Table 5: Global Market for AI Software in Biotechnology, by Region, Through 2030
Table 6: Global Market for AI in Biotechnology Services, by Region, Through 2030
Table 7: Global Market for AI in Biotechnology, by Deployment, Through 2030
Table 8: Global Market for Cloud Deployments for AI in Biotechnology, by Region, Through 2030
Table 9: Global Market for On-Premises Deployments for AI in Biotechnology, by Region, Through 2030
Table 10: Global Market for AI in Biotechnology, by Application, Through 2030
Table 11: Global Market for AI in Biotechnology for Drug Discovery, by Region, Through 2030
Table 12: Global Market for AI in Biotechnology for Clinical Trials and Optimization, by Region, Through 2030
Table 13: Global Market for AI in Biotechnology for Diagnostics, by Region, Through 2030
Table 14: Global Market for AI in Biotechnology for Other Applications, by Region, Through 2030
Table 15: Global Market for AI in Biotechnology, by End User, Through 2030
Table 16: Global Market for AI in Biotechnology for Pharma and Biotech Companies, by Region, Through 2030
Table 17: Global Market for AI in Biotechnology for Academic Research Institutes, by Region, Through 2030
Table 18: Global Market for AI in Biotechnology for Contract Organizations, by Region, Through 2030
Table 19: Global Market for AI in Biotechnology for Other End Users, by Region, Through 2030
Table 20: Global Market for AI in Biotechnology, by Region, Through 2030
Table 21: North American Market for AI in Biotechnology, by Product Type, Through 2030
Table 22: North American Market for AI in Biotechnology, by Deployment, Through 2030
Table 23: North American Market for AI in Biotechnology, by Application, Through 2030
Table 24: North American for AI in Biotechnology, by End User, Through 2030
Table 25: North American Market for AI in Biotechnology, by Country, Through 2030
Table 26: European Market for AI in Biotechnology, by Product Type, Through 2030
Table 27: European Market for AI in Biotechnology, by Deployment, Through 2030
Table 28: European Market for AI in Biotechnology, by Application, Through 2030
Table 29: European Market for AI in Biotechnology, by End User, Through 2030
Table 30: European Market for AI in Biotechnology, by Country, Through 2030
Table 31: Asia-Pacific Market for AI in Biotechnology, by Product Type, Through 2030
Table 32: Asia-Pacific Market for AI in Biotechnology, by Deployment, Through 2030
Table 33: Asia-Pacific Market for AI in Biotechnology, by Application, Through 2030
Table 34: Asia-Pacific Market for AI in Biotechnology, by End User, Through 2030
Table 35: Asia-Pacific Market for AI in Biotechnology, by Country, Through 2030
Table 36: RoW Market for AI in Biotechnology, by Product Type, Through 2030
Table 37: RoW Market for AI in Biotechnology, by Deployment, Through 2030
Table 38: RoW Market for AI in Biotechnology, by Application, Through 2030
Table 39: RoW Market for AI in Biotechnology, by End User, Through 2030
Table 40: RoW Market for AI in Biotechnology, by Sub-Region, Through 2030
Table 41: Global Ranking of Companies in the Market for AI in Biotechnology, 2024
Table 42: M&A in the AI in Biotechnology Industry, 2024-2025
Table 43: Agreements and Partnerships in the Market for AI in Biotechnology, 2023-2025
Table 44: Total Funding for AI Biotech Companies
Table 45: ESG Risk Ratings of Companies in AI Biotechnology Market, 2024
Table 46: Information Sources Used for this Report
Table 47: Abbreviations Used in this Report
Table 48: AbCellera Biologics Inc.: Company Snapshot
Table 49: AbCellera Biologics Inc.: Financial Performance, FY 2023 and 2024
Table 50: AbCellera Biologics Inc.: Product Portfolio
Table 51: AbCellera Biologics Inc.: News/Key Developments, 2023-2025
Table 52: Absci Corp.: Company Snapshot
Table 53: Absci Corp.: Financial Performance, FY 2023 and 2024
Table 54: Absci Corp.: Product Portfolio
Table 55: Absci Corp.: News/Key Developments, 2023-2025
Table 56: Atomwise Inc.: Company Snapshot
Table 57: Atomwise Inc.: Product Portfolio
Table 58: Atomwise Inc.: News/Key Developments, 2022
Table 59: BenevolentAI: Company Snapshot
Table 60: BenevolentAI: Financial Performance, FY 2022 and 2023
Table 61: BenevolentAI: Product Portfolio
Table 62: BenevolentAI: News/Key Developments, 2022-2024
Table 63: DNAnexus Inc.: Company Snapshot
Table 64: DNAnexus Inc.: Product Portfolio
Table 65: DNAnexus Inc.: News/Key Developments, 2024-2025
Table 66: Eurofins Scientific: Company Snapshot
Table 67: Eurofins Scientific: Financial Performance, FY 2023 and 2024
Table 68: Eurofins Scientific: Product Portfolio
Table 69: Eurofins Scientific: News/Key Developments, 2024
Table 70: Illumina Inc.: Company Snapshot
Table 71: Illumina Inc.: Financial Performance, FY 2023 and 2024
Table 72: Illumina Inc.: Product Portfolio
Table 73: Illumina Inc.: News/Key Developments, 2023-2025
Table 74: Insilico Medicine: Company Snapshot
Table 75: Insilico Medicine: Product Portfolio
Table 76: Insilico Medicine: News/Key Developments, 2023-2025
Table 77: Nvidia Corp.: Company Snapshot
Table 78: Nvidia Corp.: Financial Performance, FY 2023 and 2024
Table 79: Nvidia Corp.: Product Portfolio
Table 80: Nvidia Corp.: News/Key Developments, 2023-2025
Table 81: Qiagen: Company Snapshot
Table 82: Qiagen: Financial Performance, FY 2023 and 2024
Table 83: Qiagen: Product Portfolio
Table 84: Qiagen: News/Key Developments, 2025
Table 85: Recursion: Company Snapshot
Table 86: Recursion: Financial Performance, FY 2023 and 2024
Table 87: Recursion: Product Portfolio
Table 88: Recursion: News/Key Developments, 2024-2025
Table 89: Schrodinger Inc.: Company Snapshot
Table 90: Schrödinger Inc.: Financial Performance, FY 2023 and 2024
Table 91: Schrödinger Inc.: Product Portfolio
Table 92: Schrödinger Inc: News/Key Developments, 2023-2024
Table 93: Sophia Genetics: Company Snapshot
Table 94: Sophia Genetics: Financial Performance, FY 2023 and 2024
Table 95: Sophia Genetics: Product Portfolio
Table 96: Sophia Genetics: News/Key Developments, 2025
Table 97: Tempus AI Inc.: Company Snapshot
Table 98: Tempus AI Inc.: Financial Performance, FY 2023 and 2024
Table 99: Tempus AI Inc.: Product Portfolio
Table 100: Tempus AI Inc.: News/Key Developments, 2023-2025
Table 101: XtalPi Inc.: Company Snapshot
Table 102: XtalPi Inc.: Financial Performance, FY 2023 and 2024
Table 103: XtalPi Inc.: Product Portfolio
Table 104: XtalPi Inc.: News/Key Developments, 2024 and 2025
Table 105: Other Companies in the Market for AI in Biotechnology
Table 106: Emerging Startups in the AI in Biotechnology Market

List of Figures

Summary Figure: Global Market Shares of AI in Biotechnology, by Region, 2024
Figure 1: Potential Applications of AI in Biotechnology
Figure 2: Impact of AI on the Biotechnology Value Chain
Figure 3: Porter’s Five Forces Analysis of the AI in Biotechnology Industry
Figure 4: Snapshot of AI in Biotechnology Market Dynamics
Figure 5: Emerging AI Technologies in the Biotechnology Market
Figure 6: Global Market Shares of AI in Biotechnology, by Product Type, 2024
Figure 7: Global Market Shares of AI in Biotechnology, by Deployment, 2024
Figure 8: Global Market Shares of AI in Biotechnology, by Application, 2024
Figure 9: Global Market Shares of AI in Biotechnology, by End User, 2024
Figure 10: Global Market Shares of AI in Biotechnology, by Region, 2024
Figure 11: North American Market Shares of AI in Biotechnology, by Country, 2024
Figure 12: European Market Shares of AI in Biotechnology, by Country, 2024
Figure 13: Asia-Pacific Market Shares of AI in Biotechnology, by Country, 2024
Figure 14: RoW Market Shares of AI in Biotechnology, by Sub-Region, 2024
Figure 15: Investments in Biopharma AI Companies, 2019-2024
Figure 16: Market Shares of AI Biotech Startup Investment Landscape, by Funding, 2024
Figure 17: AbCellera Biologics Inc: Revenue Share, by Business Unit, FY 2024
Figure 18: AbCellera Biologics Inc: Revenue Share, by Country/Region, FY 2024
Figure 19: BenevolentAI: Revenue Share, by Country/Region, FY 2024
Figure 20: Eurofins Scientific: Revenue Share, by Business Unit, FY 2024
Figure 21: Eurofins Scientific: Revenue Share, by Country/Region, FY 2024
Figure 22: Illumina Inc.: Revenue Share, by Business Unit, FY 2024
Figure 23: Illumina Inc.: Revenue Share, by Country/Region, FY 2024
Figure 24: Nvidia Corp.: Revenue Share, by Business Unit, FY 2024
Figure 25: Nvidia Corp.: Revenue Share, by Country/Region, FY 2024
Figure 26: Qiagen: Revenue Share, by Business Unit, FY 2024
Figure 27: Qiagen: Revenue Share, by Country/Region, FY 2024
Figure 28: Schrödinger Inc.: Revenue Share, by Business Unit, FY 2024
Figure 29: Schrödinger Inc: Revenue Share, by Country/Region, FY 2024
Figure 30: Sophia Genetics: Revenue Share, by Business Unit, FY 2024
Figure 31: Sophia Genetics: Revenue Share, by Country/Region, FY 2024
Figure 32: Tempus AI Inc.: Revenue Share, by Business Unit, FY 2024
Figure 33: XtalPi Inc.: Revenue Share, by Business Unit, FY 2024
Figure 34: XtalPi Inc.: Revenue Share, by Country/Region, FY 2024

Companies Mentioned

Abcellera Biologics Inc.
Absci Corp.
Atomwise Inc.
Benevolentai
Dnanexus Inc.
Eurofins Scientific
Illumina Inc.
Insilico Medicine
Nvidia Corp.
Qiagen
Recursion
Schrodinger Inc.
Sophia Genetics
Tempus Ai Inc.
Xtalpi Inc.

Table Information

Report Attribute	Details
No. of Pages	142
Published	August 2025
Forecast Period	2025 - 2030
Estimated Market Value ( USD ) in 2025	$ 4.6 Billion
Forecasted Market Value ( USD ) by 2030	$ 11.4 Billion
Compound Annual Growth Rate	20.0%
Regions Covered	Global
No. of Companies Mentioned	15

License	Format	Properties	Price
SINGLE USER LICENSE PDF	The product is a PDF.	This is a single user license, allowing one user access to the product.	€4142EUR$4,650USD£3,594GBP
1 - 5 USER LICENSE PDF	The product is a PDF.	This is a 1-5 user license, allowing up to five users have access to the product.	€4970EUR$5,580USD£4,313GBP
SITE LICENSE PDF	The product is a PDF.	This is a site license, allowing all users within a given geographical location of your organization access to the product.	€5964EUR$6,696USD£5,175GBP
ENTERPRISE LICENSE PDF	The product is a PDF.	This is an enterprise license, allowing all employees within your organization access to the product.	€7157EUR$8,035USD£6,210GBP

Report Scope

Report Includes

Table of Contents

Companies Mentioned

Table Information

Related Topics

Related Reports

Biotechnology Market Report by Product Type, Technology, Application, and Region 2025-2033

Biotechnology Market in the US 2025-2029

Biotechnology for the Non-Biotechnologist Training Course (November 10-14, 2025)

Al in Biotechnology Market by Function (Drug Design & Optimisation, Biomarker, SAR; Clinical Trial Design, Data Assessment, RWE, Inventory, Supply Chain, Logistics; Launch, Pricing, Patient Engagement, Adverse Events), & End User - Global Forecast to 2029

Artificial Intelligence (AI) Collaboration and Licensing Deals 2019-2025